Cargando…
Switching to Integrase Inhibitors Unlinked to Weight Increase in Perinatally HIV-Infected Young Adults and Adolescents: A 10-Year Observational Study
An unexpected increase in weight gain has recently been reported in the course of integrase strand transfer inhibitors (INSTI) treatment. The possibility of this effect in people who are perinatally infected with HIV (PHIV) and thus exposed to lifelong therapy needs to be explored. This is a retrosp...
Autores principales: | Taramasso, Lucia, Di Biagio, Antonio, Bovis, Francesca, Forlanini, Federica, Albani, Elena, Papaioannu, Rebecka, Giacomet, Vania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356820/ https://www.ncbi.nlm.nih.gov/pubmed/32521616 http://dx.doi.org/10.3390/microorganisms8060864 |
Ejemplares similares
-
Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults
por: Giacomet, Vania, et al.
Publicado: (2018) -
The why and how of DNA unlinking
por: Liu, Zhirong, et al.
Publicado: (2009) -
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection
por: Sarteschi, Giovanni, et al.
Publicado: (2020) -
Immunological profile of an infant treated with integrase inhibitor from the neonatal period
por: Taramasso, Lucia, et al.
Publicado: (2019) -
Weight Gain After Switch from Efavirenz-Based to Integrase Inhibitor-Based Regimens
por: Norwood, Jamison, et al.
Publicado: (2017)